Previous 10 | Next 10 |
– Company reports first full quarter of results for Dialysate Triferic, highlighted by greater than 75% conversion rate from Triferic Evaluation Program – – Signs leading East Coast academic medical center as first Center of Excellence – WIXOM, Mich., No...
Historically, buying small-cap stocks into year-end has been savvy because of the "January Effect", a period of strong excess performance by small-cap stocks that stretches from mid-December through the following May. Over the past decade, the median return of the iShares Russell 2000 ETF (I...
WIXOM, Mich., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESR...
WIXOM, Mich., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (“Rockwell Medical” or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 third quarter financial results on Monday, November 11, 2019, after the close of the...
WIXOM, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESR...
– Encouraging progress for Triferic® portfolio – – Conference call at 8:30 am ET on Friday, October 25, 2019 – WIXOM, Mich., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), ...
Small-cap stocks have been weighed down by ongoing uncertainty associated with trade deals and interest rate policy, making it harder than ever to spot potential winners and limit risk. Although small-cap stocks could face headwinds if the economy decelerates, there are specific industries and...
Rockwell Medical ( RMTI ) received FDA approval for Dialysate Triferic, a one-of-a-kind iron maintenance medication in January 2015. In clinical trials, Triferic demonstrated improved efficacy and less risk than currently approved intravenous iron products. Despite these advantages, the Center...
Small-cap stocks have underperformed large-cap stocks, and recent manufacturing and services industry data increases concerns that profits could stagnate. The risk of decelerating economic activity to small-cap stocks shouldn't be ignored, but that doesn't mean there aren't sectors, industries...
WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at the 2019 Cantor Global Healthcare Conference as follows: The presentati...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...